Franzosi Dal Negro Setti with Muscolo (Milan)

Gabriella Muscolo

Franzosi Dal Negro Setti with Muscolo (Milan)
Partner / Lecturer

Gabriella is a partner and the head of the Antitrust Department at Franzosi Dal Negro Setti with Muscolo in Milan and Rome. She is a former Commissioner of the Italian Competition Authority, a former IP and Competition Law Judge at the Court of Rome and a former member of the Enlarged Board of Appeal- EBA of the European Patent Office-EPO. Gabriella is a deputy member of the Board of Appeal Committee- BOAC at the EPO. She is a Fellow of the Centre of European Law at Kings College London and teaches at the postgraduate course on Competition and Innovation at Luiss University . She has lectured in several University in Italy and abroad. Gabriella is a member of the Advisory Board of Concurrences e-Competitions Bulletin Boards and a member of the Board of Trustees of ERA (Academy of European Law) and of the Advisory Board of the ERA Forum (Journal of the Academy of European Law). She publishes in Italian as well as in English in the fields of Intellectual Property and Competition Law, and has also published for Concurrences. Gabriella co- edited the volumes “Intellectual Property and Competition Law : a European perspective “The Pharmaceutical Sector Between Patent Law and Competition Law. An International Perspective”, with Giovanni Pitruzzella, “The Interplay Between Competition Law and Intellectual Property : An International Perspective” with Marina Tavassi, and “ After the damages directive:Policy and Practice in the EU Member States and the United Kingdom, with Andrea Biondi e Renato Nazzini.


Gabriella Muscolo (Italian Competition Authority)
Gabriella Muscolo 7 octobre 2019 Paris
Gabriella Muscolo (AGCM)
Gabriella Muscolo 3 juillet 2019 Milan
Gabriella Muscolo (AGCM)
Gabriella Muscolo 24 janvier 2018 Milan


4502 Bulletin

Gabriella Muscolo, Luca Arnaudo Patent Settlements : An overview of US, EU and national case law


Pharmaceutical activities have always been patent-sensitive, according to applicable legal frameworks. However, the vertical increase in W16 patenting since the 1980s has transformed the industrial and competitive dynamics of the sector, making it fundamentally IPRs intensive. Add to this impressive trend the extraordinarily complex and expanding web of market exclusivities associated with IPRs based on specific therapeutic features (say, the growing relevance of orphan drugs for treating rare diseases), and it is easy to understand how patent litigation – and related settlement opportunities – has become a central battleground for pharmaceutical companies. Accordingly, and proportionally to the number of patents, the possibility of using patents in an anti-competitive manner has been unleashed, with IPRs becoming a formidable tool (also) for defending monopolistic positions far beyond the original intentions of the patent system envisaged for the sector.

Gabriella Muscolo Italy & COVID-19 : An overview of EU and national case law


The health crisis has struck the entire world, challenging leaders to take unprecedented measures in order to control the spread of Covid-19. On 10 March 2020, Italy, in particular, was the first European Country to implement the strict lockdown, thereby leading the way for other countries. (...)

14943 Revue

Giandonato Caggiano, Gabriella Muscolo, Marina Tavassi Competition Law and Intellectual Property : A European Perspective, Giandonato CAGGIANO, Gabriella MUSCOLO et Marina TAVASSI


Cette rubrique Livres recense et commente les ouvrages et autres publications en droit de la concurrence, droit & économie de la concurrence et en droit de la régulation. Une telle recension ne peut par nature être exhaustive et se limite donc à présenter quelques publications récentes dans ces (...)

Alden F. Abbott, Robin Adelstein, Megan Browdie, Michael A. Carrier, Peter C. Carstensen, Samuel Clark, Lisl J. Dunlop, Harry First, Albert A. Foer, Eleanor M. Fox, Jacqueline Grise, Ryan Kantor, Donald C. Klawiter, John Kwoka, James Langenfeld, Tad Lipsky, Alessandro Massolo, Howard Morse, Gabriella Muscolo, James Bo Pearl, Noah Pinegar, Chris Ring, Christopher Sagers, Richard S. Taffet, Willard K. Tom, Eliot Turner, Doug Tween, Tommaso Valletti, Michael L. Weiner The new US antitrust administration


Ce dossier Concurrences se concentre sur l’antitrust et ses possibles développements à la suite des élections présidentielles américaines. Il s’interroge sur les changements et défis attendus pour 2021 sous la nouvelle administration Biden, et leurs impacts sur la législation et la politique de la (...)

Paul Belleflamme, Francisco Costa Cabral, Tim Cowen, Daniel Fasquelle, Paula Forteza, Inge Graef, Max Huffman, Frédéric Marty, Jacques Moscianese, Gabriella Muscolo, Martin Peitz, Sebastien Soriano, Thierry Warin, Ramsi Woodcock Digital & competition


Cette série d’articles illustre le débat sur le rôle de la politique de concurrence dans l’économie numérique. Chaque contribution aborde le sujet sous un angle différent. Les deux premières traitent des stratégies non tarifaires pratiquées par les plateformes numériques monopolistiques et des remèdes qui (...)


Envoyer un message